Adapting Analytical Development Strategies Across Clinical Trial Phases
Time: 4:50 pm
day: Conference Day One Afternoon
Details:
- Delve into the shifting landscape of analytical development strategies from early clinical trials to post-approval phases, highlighting the evolving needs and challenges at each stage.
- Explore the unique challenges encountered during transitions between clinical trial phases and discuss strategies for adapting analytical methodologies to address changing requirements effectively.
- Focus on post-approval analytical strategies aimed at maintaining product efficacy and safety over the long term, emphasizing the importance of continuous monitoring and refinement in response to real-world data and feedback.
